KALA BIO, Inc. (KALA) Stock

Healthcare · Biotechnology · Member of Other US Stocks

KALA BIO, Inc. (KALA) closed at USD 0.19 on 2026-10-15, a change of -99.5 % over the past year, with a market capitalization of USD 3.67M.

KALA BIO, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

KALA BIO, Inc. key figures

Previous close

USD 0.19 (2026-10-15)

1-year change

-99.5 %

Market cap

USD 3.67M

Enterprise value

USD -3.56M

P/E ratio (trailing)

-0.02

P/E ratio (forward)

-0.03

EPS (trailing)

-10.71

EPS (forward)

-6.67

PEG ratio

n/a

Price to book

0.41

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.37

Employees

6

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About KALA BIO, Inc.

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for KALA BIO, Inc. and compare it with other stocks.